Company: LRHC
Filing Date: 2025-07-17
Form Type: 424B3
Source: 0001213900-25-065175
Chunk: 31

Company: La Rosa Holdings Corp.
Filing Date: 2025-07-17
Form: 424B3
Chunk 31
---
 acquisitions and general corporate purposes. The Company also
granted the Selling Stockholder registration rights in the shares of common stock offered hereby under the Registration Rights Agreement
(as defined below).

Pursuant to the terms of the SPA, the Company
is required, as promptly as practicable but prior to the sixtieth (60th) calendar day after the Closing Date, to obtain the prior written
consent of the requisite stockholders (the “Stockholder Consent”) to obtain the Stockholder Approval (as defined below) and
inform the stockholders of the Company of the receipt of the Stockholder Consent by preparing and filing with the SEC an information
statement with respect thereto. The Company has heretofore obtained the Stockholder Consent from the majority stockholders of the Company,
which approves the following matters (collectively, the “Stockholder Approval”): (i) the issuance of the Initial Note, the
Incremental Warrants, the Incremental Notes, and all Conversion Shares and Incremental Conversion Shares (as defined below) in excess
of 19.99% of the Company’s issued and outstanding common stock at a price less than the minimum price required by Nasdaq, in compliance
with the rules and regulations thereof; (ii) authorization to complete a reverse split of the common stock; and (iii) authorization to
increase the authorized common stock of the Company to ensure that the number of authorized shares is sufficient to meet the Required
Reserve Amount (as defined in the SPA). The Stockholder Consent will not become effective until twenty (20) calendar days after such
information statement is first mailed or otherwise delivered to holders of common stock as of the relevant record date.

The SPA contained customary representations and warranties and agreements and obligations of the parties. The proceeds of this financing will be used for business development and general working capital purposes.

As we reported in our Current Report on Form 8-K filed with the SEC on June 20, 2025, on June 18, 2025, with the prior approval by the Company’s Board of Directors, the Company and the Selling Stockholder entered into, and closed the transactions contemplated by, that certain Amendment and Exchange Agreement (the “Exchange Agreement”) pursuant to which (among other things) the Selling Stockholder surrendered and exchanged all of its Incremental Warrants in exchange for (the “Exchange”) 6,000 shares of the Company’s Series B Convertible Preferred Stock, par value $0.0001 per share (“Series B Preferred Stock